Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with alzheimer's disease

Journal of Alzheimer's Disease

Volumn 27, Issue 1, 2011, Pages 143-153

  Cornejo, Alberto ^a   Jiménez, José M ^a   Caballero, Leonardo ^b   Melo, Francisco ^b   MacCioni, Ricardo B ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

Author keywords

Alzheimer's disease; atomic force microscopy; disassembly; fulvic acid; tau aggregation

Indexed keywords

FULVIC ACID; TAU PROTEIN;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FIBER; IN VITRO STUDY; PAIRED HELICAL FILAMENT; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION;

EID: 80155161291     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-110623     Document Type: Article

References (35)

1. Maccioni RB, Munoz JP, Barbeito L (2001) The molecular bases of Alzheimer's disease and other neurodegenerative disorders. Arch Med Res 32, 367-381. (Pubitemid 32918139)
2. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci USA 83, 4913-4917.
3. Ballatore C, Lee VM, Trojanowski JQ (2007) Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat Rev Neurosci 8, 663-672. (Pubitemid 47283144)
4. Dickson DW, Crystal HA, Bevona C, Honer W, Vincent I, Davies P (1995) Correlations of synaptic and pathological markers with cognition of the elderly. Neurobiol Aging 16, 285-298; discussion 298-304.
5. Guillozet AL, Weintraub S, Mash DC, Mesulam MM (2003) Neurofibrillary tangles, amyloid, and memory in aging and mild cognitive impairment. Arch Neurol 60, 729-736. (Pubitemid 36569891)
6. van Swieten J, Spillantini MG (2007) Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol 17, 63-73.
7. Oddo S, Vasilevko V, Caccamo A, Kitazawa M, Cribbs DH, LaFerla FM (2006) Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles. J Biol Chem 281, 39413-39423. (Pubitemid 46041901)
8. Khlistunova I, Biernat J,WangY, Pickhardt M, von Bergen M, Gazova Z, Mandelkow E, Mandelkow EM (2006) Inducible expression of tau repeat domain in cell models of tauopathy: Aggregation is toxic to cells but can be reversed by inhibitor drugs. J Biol Chem 281, 1205-1214.
9. Holmes C, Boche D,Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JA (2008) Long-term effects of Abeta42 immunisation in Alzheimer's disease: Follow-up of a randomised, placebocontrolled phase I trial. Lancet 372, 216-223. (Pubitemid 351978111)
10. Rinne JO, Brooks DJ, Rossor MN, Fox NC, Bullock R, Klunk WE, Mathis CA, Blennow K, Barakos J, Okello AA (2010) Rodriguez Martinez de Liano S, Liu E, Koller M, Gregg KM, Schenk D, Black R, GrundmanM11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: A phase 2, double-blind, placebo-controlled, ascending-dose study. Lancet Neurol 9, 363-372.
11. Extance A (2010) Alzheimer's failure raises questions about disease-modifying strategies. Nat Rev Drug Discov 9, 749-751.
12. Brunden KR, Trojanowski JQ, Lee VM (2009) Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat Rev Drug Discov 8, 783-793.
13. Bulic B, Pickhardt M, Schmidt B, Mandelkow EM, Waldmann H, Mandelkow E (2009) Development of tau aggregation inhibitors for Alzheimer's disease. Angew Chem Int Ed Engl 48, 1740-1752.
14. Wischik CM, Edwards PC, Lai RY, Roth M, Harrington CR (1996) Selective inhibition of Alzheimer disease-like tau aggregation by phenothiazines. Proc Natl Acad Sci USA 93, 11213-11218. (Pubitemid 26333144)
15. Taniguchi S, Suzuki N, Masuda M, Hisanaga S, Iwatsubo T, Goedert M, Hasegawa M (2005) Inhibition of heparin-induced tau filament formation by phenothiazines, polyphenols, and porphyrins. J Biol Chem 280, 7614-7623. (Pubitemid 40349654)
16. Wischik CM, Bentham P, Wischik DJ, Seng KM (2008) Tau aggregation inhibitor (TAI) theraphy with Rember arrests disease progression in mild and moderate Alzheimer's disease over 50 weeks. Alzheimers Dement 4 (Suppl), T167.
17. Porat Y, Abramowitz A, Gazit E (2006) Inhibition of amyloid fibril formation by polyphenols: Structural similarity and aromatic interactions as a common inhibition mechanism. Chem Biol Drug Des 67, 27-37. (Pubitemid 43881385)
18. Bastianetto S, Krantic S, Quirion R (2008) Polyphenols as potential inhibitors of amyloid aggregation and toxicity: Possible significance to Alzheimer's disease. Mini Rev Med Chem 8, 429-435.
19. Kim J, Lee HJ, Lee KW (2010) Naturally occurring phytochemicals for the prevention of Alzheimer's disease. J Neurochem 112, 1415-1430.
20. Peterson DW, George RC, Scaramozzino F, LaPointe NE, Anderson RA, Graves DJ, Lew J (2009) Cinnamon extract inhibits tau aggregation associated with Alzheimer's disease in vitro. J Alzheimers Dis 17, 585-597.
21. Pasinetti GM, Ksiezak-Reding H, Santa-Maria I,Wang J, Ho L (2010) Development of a grape seed polyphenolic extract with anti-oligomeric activity as a novel treatment in progressive supranuclear palsy and other tauopathies. J Neurochem 114, 1557-1568.
22. Leenheer JA (2007) Progression from model structures to molecular structures of natural organic matter components. Ann Environ Sci 1, 57-68.
23. Ghosal S, Lal J, Jaiswal AK, Bhattacharya SK (1993) Effects of shilajit and its active constituents on learning and memory in rats. Phytother Res 7, 29-34. (Pubitemid 23044563)
24. Wang C, Wang Z, Peng A, Hou J, Xin W (1996) Interaction between fulvic acids of different origins and active oxygen radicals. Sci China C Life Sci 39, 267-275. (Pubitemid 126468000)
25. Corsaro A, Anselmi C, Polano M, Aceto A, Florio T, De Nobili M (2010) The interaction of humic substances with the human prion protein fragment 90-231 affects its protease K resistance and cell internalization. J Biol Regul Homeost Agents 24, 27-39.
26. Pickhardt M, Gazova Z, von Bergen M, Khlistunova I, Wang Y, Hascher A, Mandelkow EM, Biernat J, Mandelkow E (2005) Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells. J Biol Chem 280, 3628-3635. (Pubitemid 40223830)
27. Crowe A, Ballatore C, Hyde E, Trojanowski JQ, Lee VM (2007) High throughput screening for small molecule inhibitors of heparin-induced tau fibril formation. Biochem Biophys Res Commun 358, 1-6. (Pubitemid 46719073)
28. Wegmann S, Jung YJ, Chinnathambi S, Mandelkow EM, MandelkowE, Muller DJ (2010) Human Tau isoforms assemble into ribbon-like fibrils that display polymorphic structure and stability. J Biol Chem 285, 27302-27313.
29. Burdick D, Soreghan B, Kwon M, Kosmoski J, Knauer M, Henschen A, Yates J, Cotman C, Glabe C (1992) Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J Biol Chem 267, 546-554.
30. Ding Y, Qiao A, Wang Z, Goodwin S, Lee ES, Block M, Allsbrook M, McDonald M, Fan GH (2008) Retinoic acid attenuates Beta-amyloid deposition and rescues memory deficit in an Alzheimeŕs disease transgenic mouse model. J Neurosci 28, 11622-11634.
31. Lee HP, Casadesus G, Zhu X, Lee HG, Perry G, Smith MA, Gustaw-Rothenberg K, Lerner A (2009) All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease. Expert Rev Neurother 9, 1615-1621.
32. Gotz J, Chen F, van Dorpe J, Nitsch RM (2001) Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Abeta 42 fibrils. Science 293, 1491-1495. (Pubitemid 32807681)
33. Roberson ED, Scearce-Levie K, Palop JJ, Yan F, Cheng IH, Wu T, Gerstein H, Yu GQ, Mucke L (2007) Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science 316, 750-754. (Pubitemid 46717684)
34. Ho L, Yemul S, Wang J, Pasinetti GM (2009) Grape seed polyphenolic extract as a potential novel therapeutic agent in tauopathies. J Alzheimers Dis 16, 433-439.
35. Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Lurz R, Engemann S, Pastore A,Wanker EE (2008) EGCG redirects amyloidogenic polypeptides into unstructured, offpathway oligomers. Nat Struct Mol Biol 15, 558-566. (Pubitemid 351799141)